"What do holders make of this? Took me by surprise."
Personally, I am not a fan of companies making corporate acquisitions.
My experience is that it invariably results in a transfer of value from the acquirer to the shareholders of the company being acquired.
From what I can discern - on the basis of the limited research I've done on the business RMD is buying - this is a meaningful departure from Resmed's core competency of the diagnosis and treatment of sleep disorders.
This is most a unusual thing for Resmed to do.
In summary, I am not very happy about it.
It worries me.
Ann: ResMed to Acquire Brightree, page-3
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
